Find a Clinical Trial

Functional Imaging for Ocular Blood Flow with OCTA

Novel Functional Imaging for Ocular blood flow with Optical Coherence Tomography Angiography

18+

Learn more

OCS Heart Perfusion Registry

OCS Heart Perfusion Post- Approval Registry

18+

Learn more

Decartes-08 for Myasthenia Gravis

OGOUS T-CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR
DIRECTED TO B-CELL MATURATION ANTIGEN (BCMA) IN PATIENTS
WITH GENERALIZED MYASTHENIA GRAVIS (MG)

18+

Learn more

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

18+

Learn more

SOS

Orthopaedic Sports Medicine, Arthoscopy, and Related Surgery Registry Using the Web-Based Surgical Outcomes System

12+

Learn more

PBCAR0191

Phase 1/2a, Open-label, Dose-escalation, Dose-expansion, Parallel Assignment Study to Evaluate Safety and Clinical Activity of PBCAR0191 in Subjects With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

18+

Learn more

Armata Bacteriophage Study; disArm Study

Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP-SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiotic Therapy Alone for the Treatment of Adults With Bacteremia Due to Staphylococcus aureus.

18-100

Learn more

NRG-BN009

Phase III Trial of Salvage Stereotactic Radiosurgery (SRS) or SRS + Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for First or Second Distant Brain Relapse After Upfront SRS With Brain Metastasis Velocity ≥4 Brain Metastases/Year

18+

Learn more

Schiller Grant BC

Phenotyping Heart Failure Readmission Risk using Wearable Sensors and Machine Learning

21+

Learn more

THC-AD

Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer’s disease (AD) (THC-AD)

60-95

Learn more